3D Printing startup ecosystem

C CurifyLabs

CurifyLabs is a Helsinki-based HealthTech company automating the production of personalised medicines. Its Compounding System Solution combines proprietary software, GMP-manufactured excipient bases, and 3D-printing hardware (including the PharmaPrinter Aurum) to let pharmacies compound and dispense custom-dosed medications up to nine times faster than manual methods. Founded in 2021 by Charlotta Topelius and Niklas Sandler — a professor of pharmaceutical technology at Åbo Akademi University with over a decade researching automated compounding — the company's technology is already in use across pharmacies in 21 U.S. states and multiple European countries. In July 2026, CurifyLabs closed a $14 million Series A, co-led by Sandwater and HealthCap with participation from Tesi (Finnish Industry Investment Ltd.) and existing investor Lifeline Ventures, to expand its compounding platform.